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INTRODUCTION:  Undifferentiated  carcinomas  with osteoclast-like  giant  cells  (UC-OGCs)  of the  ampullary
region are  very  rare,  with  only  a  few  cases  reported  to date.  The  clinicopathological  features,  treatment
options,  and  prognosis  of  UC-OGCs  are  unclear.  This  report  describes  a patient  with  UC-OGCs  of the
ampullary  region.
PRESENTATION  OF  CASE:  A  78-year-old  male  patient  was  admitted  for epigastric  pain  and  fever.  Contrast-
enhanced  computed  tomography  revealed  a 2.6-cm  mass  at the duodenal  papilla.  Duodenoscopy  revealed
a smooth  red  protruding  mass  compressing  the  oriﬁce  of  the papilla  of  Vater.  Biopsy  of the  mass  showed
proliferation  of  osteoclast-like  giant  cells.  A subtotal  stomach-preserving  pancreaticoduodenectomy  was
performed, and  the tumor  was  histologically  diagnosed  as  an  UC-OGCs  of the ampullary  region.  Carcinoma
in  situ  was  also  observed,  spreading  from  the  tumor  at the  terminal  segment  of the  common  bile  duct  to
the  common  hepatic  duct,  with  carcinoma  cells  at the surgical  margin  of  the  common  hepatic  duct.  One
year after  surgery,  the  patient  is  alive  and  without  tumor  recurrence.
DISCUSSION:  UC-OGCs  of  the  ampullary  region  is very  rare  neoplasm  containing  osteoclast-like  giant  cells
and  mononuclear  cells.  Osteoclast-like  giant cells  may  originate  from  reactive  mesenchymal  cells  and
carcinoma  in  situ may  spread  to the  common  hepatic  duct.  Surgery  including  pancreaticoduodenectomy
may be  a treatment  option  for resectable  tumors,  whereas  gemcitabine  may  be  a treatment  option  for
unresectable  tumors.
CONCLUSION: Carcinoma  in  situ  may  spread  quite  far (5 cm)  to  the  common  hepatic  duct,  making  it
desirable  to intraoperatively  conﬁrm  negative  bile  duct  margins  by rapid  pathologic  diagnosis.
© 2016  The  Author(s).  Published  by  Elsevier  Ltd  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Undifferentiated carcinomas with osteoclast-like giant cells
UC-OGCs), similar to those present in long bones, have been
bserved in many organs but are generally rare. These tumors occur
ore frequently in the gallbladder and pancreas than in extrahep-
tic bile ducts and the ampullary region [1]. Because there have
een few case reports of UC-OGCs of the ampullary region, their
linical features and treatment strategies are not well understood.
his report describes a patient with UC-OGCs of the ampullary
egion who was successfully treated with surgery.∗ Corresponding author at: Department of Surgery, Kurashiki Central Hospital,
-1-1 Miwa,  Kurashiki, 710-8602 Okayama, Japan.
E-mail addresses: yk13105@kchnet.or.jp (Y. Kawamoto), yo14408@kchnet.or.jp
Y. Ome), kt13958@kchnet.or.jp (K. Terada), kh14813@kchnet.or.jp (K. Hashida),
k7159@kchnet.or.jp (K. Kawamoto), ti4820@kchnet.or.jp (T. Ito).
ttp://dx.doi.org/10.1016/j.ijscr.2016.04.057
210-2612/© 2016 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2. Presentation of case
A previously healthy 78-year-old male patient was admitted to
our hospital because of epigastric pain and fever. Over the previ-
ous month, he had unintentionally lost 4.0 kg in weight. Physical
examination showed no evidence of abdominal tenderness or a pal-
pable mass. Laboratory examination showed anemia (hemoglobin,
10.3 g/dl) and elevated serum concentrations of alkaline phos-
phatase (ALP) was  1876 IU/l, gamma  glutamyl transpeptidase
(-GTP; 373 IU/l), lipase (87 IU/l), aspartate aminotransferase (AST;
77 IU/l), and alanine aminotransferase (ALT; 117 IU/l). His total
bilirubin concentration was 0.7 mg/dl, his carbohydrate antigen 19-
9 (CA19-9) concentration was 5.3 U/ml (normal <37.0 U/ml) and
his carcinoembryonic antigen (CEA) concentration was 1.5 ng/ml
(normal < 5.0 ng/ml). Contrast-enhanced computed tomography
(CECT) showed an approximately 2.6 × 1.5 cm mass at the duo-
denal papilla, enhanced in the arterial phase but washed-out in
the venous phase (Fig. 1a). There was  no evidence of lymph node
metastasis or invasion of the common bile duct or pancreatic duct.
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. (a) Abdominal CT scan showing an approximately 2.6 × 1.5 cm mass enhanced i
enlargement of the tumor, to 3.8 × 2.7 mm.
Fig. 2. Duodenoscopy results, showing a smooth red protruding mass compressing
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ture found only two previous reports of UC-OGCs of the ampullary
region (Table 1). All patients were elderly(>70 years) and pre-he  oriﬁce of the papilla of Vater.
uodenoscopy revealed a smooth red protruding mass compress-
ng the oriﬁce of the papilla of Vater, making endoscopic retrograde
holangiopancreatography difﬁcult (Fig. 2). Endoscopic ultrasonog-
aphy showed dilation of the pancreatic duct and common bile duct.
 biopsy of the mass showed proliferation of osteoclast-like giant
ells. Follow-up CECT 1 month later showed enlargement of the
umor, to 3.8 × 2.7 mm (Fig. 1b). Therefore, we performed subto-
al stomach-preserving pancreaticoduodenectomy (SSPPD) with
egional lymphadenectomy.
Macroscopic examination of the duodenum showed a protrud-
ng mass, measuring 50 × 40 × 35 mm,  located in the periampulla
f the duodenum (Fig. 3a). Microscopically, the tumor was found
o originate from the terminal segment of the common bile duct
n the ampullary region (Fig. 3b). The area of the tumor protrud-
ng into the duodenum consisted of sheets of anaplastic round and
void giant cells or fascicles of spindle cells mixed with multinucle-
ted osteoclast-like giant cells. The former cells were negative for
pithelial membrane markers like AE1/AE3, EMA  and negative for
D68 while the later cells were negative for AE1/AE3, EMA  and posi-
ive for CD68 (Fig. 3c). Carcinoma in situ (BilIN 3) was also observed,
preading from the terminal segment of the common bile duct to
he common hepatic duct and the cystic duct. The surgical mar-
in of the common hepatic duct was positive (Fig. 3d). There was
o evidence of lymph node metastasis, lymphatic or vascular inva-
ion, or invasion to the pancreas, pancreatic duct, or duodenum.
he ﬁnal diagnosis was UC-OGCs of the ampullary region, with then an arterial phase. (b) Follow up CECT 1 month after admission, showing rapid
tumor staged as T1, N0, M0,  stage IA according to the TNM staging
system.
Twelve days after surgery, the patient was  discharged from hos-
pital without any complications. One year after surgery, the patient
remains alive, with follow-up abdominal CT scan showing no evi-
dence of tumor recurrence.
3. Discussion
Although generally rare, UC-OGCs similar to those in the long
bones have been detected in many organs, including soft tissue of
the extremities [2], as well as the mediastinum [3], larynx [4] and
skin [5]. In visceral organs, this neoplasm is more common in the
gallbladder and pancreas than in the extrahepatic bile ducts and
ampullary region [1]. The ampullary region contains the sphincter
of Oddi, which acts as a channel leading from the point at which the
common bile duct enters the wall of the duodenum into the major
duodenal papilla [6]. In our patient, the tumor was originated from
the terminal segment of the common bile duct and had not spread
into the pancreatic duct or duodenum, resulting in a diagnosis of a
UC-OGCs of the ampullary region.
Histologically, UC-OGCs are composed of two types of cells:
osteoclast-like giant cells and mononuclear cells. Proposed origins
of the osteoclast-like giant cells have included neoplastic acinar
cells, neoplastic ductal cells, neoplastic epithelial cells, neoplas-
tic mesenchymal cells, and reactive mesenchymal cells [1]. In our
patient, osteoclast-like giant cells were lack of atypia, and positive
for CD68 while negative for cytokeratin. These results may  support
the hypothesis that the osteoclast-like giant cells are originated
from reactive mesenchymal cells. Preoperative biopsy of the mass
in our patient showed proliferation of osteoclast-like giant cells
without carcinoma cells. However, the presence of osteoclast-like
giant cells raises the possibility of the presence of the neoplastic
mononuclear cells. Because lymph node metastasis was reported
in UC-OGCs of pancreas [7,8], we  chose to perform pancreaticoduo-
denectomy with regional lymphadenectomy. UC-OGCs of pancreas
accompanying PanIN lesions has reported [9]. In our patient, BilIN
3 was found in the terminal segment of the common bile duct, close
to the anaplastic tumor; however, we could not detect areas of tran-
sition between BilIN 3 lesions and anaplastic tumor components.
BilIN 3 may  spread more than 40 mm  from the macroscopic tumor
margins of bile duct carcinoma [10]. In our patient, BilIN 3 had
spread more than 50 mm.  Negative bile duct margins of UC-OGCs
of the ampullary region should be conﬁrmed intraoperatively by
rapid pathologic diagnosis.
Because of the rarity of UC-OGCs of the ampullary region, their
clinicopathological features remain unclear. A search of the litera-sented with unspeciﬁc symptoms like abdominal pain or without
symptoms. The prognosis of patients with carcinomas containing
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Fig. 3. (a) Macroscopic ﬁndings of the duodenum, showing a fungiform exposed protruding mass, 50 × 40 × 35 mm, located in the periampulla of the duodenum. (b)
Microscopically, the tumor was located mainly in the ampullary region, originating from the terminal segment of the common bile duct in the ampullary region. (c) Histologic
examination showed that the tumor consisted of sheets of anaplastic round, ovoid or spindle giant cells admixed with multinucleated osteoclast-like giant cells. (d) Carcinoma
in  situ was  observed, continuously spreading from the tumor at the terminal segment of the common bile duct to the common hepatic duct and cystic duct.
Table 1
Clinical and pathological features of patients with UC-OGC in the ampullary region.
case author age/sex Clinical Presentation location size (cm) surgery other therapy follow up
1 Molberg [1] 85/F NA ampullary 3.5 local resection none DOD  6 months
2  Matsuzawa [14] 71/F abdominal pain ampullary 6 Pancreaticoduodenectomy gemcitabine Alive 24 months
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A; not available, DOD; dead of disease.
steoclast-like giant cells is unclear. For example, the prognosis of
atients with UC-OGCs of the breast is similar to that of patients
ith invasive breast cancer. The prognosis of undifferentiated car-
inoma of the pancreas is also poor, with a median survival period
f less than 1 year [11]. Older age, males, small tumors, positive
etastases and a concomitant component of ductal adenocarci-
oma are suggested as poor prognostic factors of UC-OGCs of
ancreas [12]. Owing to their asymptomatic nature, UC-OGCs of
he pancreas are usually not detected until they are quite large and
ave reached advanced stages with widespread metastases. UC-
GCs of the ampullary region may  also be difﬁcult to detect early,
ecause tumor in ampullary region often lack symptoms in early
tage [13]. Almost all patients with UC-OGCs of the pancreas who
ave survived for a long time have undergone surgery. The reported
atient of UC-OGCs in the ampullary region who survived more
han 2 years was performed pancreaticoduodenectomy [14] while
he other reported patient of UC-OGCs in the ampullary region who
ied within 6 month was performed only local resection [1]. These
esults may  suggest that pancreaticoduodenectomy may  be the
reatment of choice for resectable UC-OGCs in the ampullary region.
ur patient was performed pancreaticoduodenectomy, which may
ead to a short-term survive even though the surgical margin of
he common hepatic duct was positive [15]. Although there is no
tandard chemotherapy for UC-OGCs of the ampullary region and
elated metastases, gemcitabine induced a complete response in
 patient with recurrent liver and para-aortic lymph node lesions5 Pancreaticoduodenectomy none Alive 12 months
following surgical resection of a UC-OGCs of the ampullary region
[14]. In addition, gemcitabine was found effective in a patient with
UC-OGC of the pancreas [16], suggesting that gemcitabine would
be feasible in patients with unresectable or recurrent UC-OGCs of
the ampullary region. Larger case series and longer term follow-
up are necessary to clarify the clinicopathological features, surgical
outcome and effects of chemotherapy in patients with UC-OGCs of
the ampullary region.
4. Conclusion
Surgery, including pancreaticoduodenectomy, appears to be a
fair treatment option for patients with resectable UC-OGCs of the
ampullary region. Carcinoma in situ may  spread quite far (5 cm)  to
the common hepatic duct, making it important to intraoperatively
conﬁrm negative bile duct margins by rapid pathologic diagnosis.
Conﬂict of interest
The authors have no conﬂicts of interest.Funding
None.
 –  O
2 al of S
E
C
p
A
o
K
K
G
R
[
[
[
[
[
[
O
T
p
cCASE  REPORT
02 Y. Kawamoto et al. / International Journ
thical approval
Ethical approval not required.
onsent
Written informed consent was obtained from the patient for
ublication of this case report and accompanying images.
uthor contributions
Yusuke Kawamoto, Yusuke Ome, Kazuki Hashida performed the
peration. Kazuhiro Terada made pathological diagnosis. Yusuke
awamoto wrote the manuscript, while Yusuke Ome, Kazuyuki
awamoto and Tadashi Ito critically revised it.
uarantor
Yusuke Kawamoto.
eferences
[1] K.H. Molberg, C. Heffess, R. Delgado, J. Albores-Saavedra, Undifferentiated
carcinoma with osteoclast-like giant cells of the pancreas and periampullary
region, Cancer 82 (1998) 1279–1287.
[2] L. Angervall, B. Hagmar, L.G. Kindblom, et al., Malignant giant cell tumor of
soft tissues: a clinicopathologic, cytologic, ultrastructural, angiographic, and
microangiographic study, Cancer 47 (1981) 736–747.
[3] K. Fu, C.A. Moran, S. Suster, Primary mediastinal giant cell tumors: a
clinicopathologic and immunohistochemical study of two  cases, Ann. Diagn.
Pathol. 6 (2002) 100–105.
[
pen Access
his article is published Open Access at sciencedirect.com. It is distrib
ermits unrestricted non commercial use, distribution, and reproduct
redited.PEN  ACCESS
urgery Case Reports 24 (2016) 199–202
[4] J.A. Wieneke, F.H. Gannon, D.K. Heffner, et al., Giant cell tumor of the larynx: a
clinicopathologic series of eight cases and a review of the literature, Mod.
Pathol. 14 (2001) 1209–1215.
[5] P. Maheswaran, B.J. Addis, Osteoclastoma-like giant cell tumour of the skin,
Histopathology 16 (1990) 604–607.
[6] Japanese Society of Biliary Surgery, Classiﬁcation of Biliary Tract Carcinoma,
second english edition, Kanehara, Tokyo, 2004.
[7] M.J. Newbould, E.W. Benbow, A. Sene, et al., Adenocarcinoma of the pancreas
with osteoclast-like giant cells: a case report with immunocytochemistry,
Pancreas 7 (1992) 611–615.
[8] Sungho Jo, Huge undifferentiated carcinoma of the pnacreas with
steoclast-like giant cells, World J. Gastroenterol. 20 (2014) 2725–2730.
[9] F. Bergmann, I. Esposito, C.W. Michalski, et al., Early undifferentiated
pancreatic carcinoma with osteoclastlike giant cells: direct evidence for
ductal evolution, Am.  J. Surg. Pathol. 31 (2007) 1919–1925.
10] T. Ebata, H. Watanabe, Y. Ajioka, K. Oda, Y. Nimura, Pathological appraisal of
lines of resection for bile duct carcinoma, Br. J. Surg. 89 (2002) 1260–1267.
11] S. Kobayashi, H. Nakano, N. Ooike, et al., Long-term survivor of a resected
undifferentiated pancreatic carcinoma with osteoclast-like giant cells who
underwent a second curative resection: a case report and review of the
literature, Oncol. Lett. 8 (2014) 1499–1504.
12] R. Holland, U.J. van Haelst, Mammary carcinoma with osteoclastlike giant
cells: additional observations of six cases, Cancer 53 (1984) 1963–1973.
13] J.M. Winter, J.L. Cameron, K. Olino, et al., Clinicopathologic analysis of
ampullary neoplasms in 450 patients: implications for surgical strategy and
long-term prognosis, J. Gastrointest. Surg. 14 (2010) 379–387.
14] G. Matsuzawa, K. Shirabe, T. Gion, et al., Surgecally resected undifferentiated
carcinoma with osteoclast-like giant cells of the periampullary region
involving the oriﬁce of the papilla of vater: report of a case, Surg. Today 40
(2010) 376–379.
15] Y. Nakanishi, S. Kondo, Y. Zen, et al., Impact of residual in situ carcinoma on
postoperative survival in 125 patients with extrahepatic bile duct carcinoma,
J.  Hepatobiliary Pancreat. Sci. 17 (2010) 166–173.
16] M.  Yoshioka, H. Uchinami, G. Watanabe, et al., Effective use of gemcitabine in
the  treatement of undifferentiated carinoma with osteoclast-like giant cells of
the pancreas with portal vein tumor thorombus, Intern. Med. 51 (2012)
2145–2150.
uted under the IJSCR Supplemental terms and conditions, which
ion in any medium, provided the original authors and source are
